INOVIO Pharmaceuticals’ $36 Million Common Stock Offering

Cooley advised INOVIO Pharmaceuticals, while Paul Hastings LLP advised Oppenheimer & Co. and Citizens JMP as joint book running managers in the offering.INOVIO executed an underwritten…

This content is for Standard 1 Year members only.
Login Join Now

Tyfon’s Business Combination with Global Technology Acquisition Corp. I

Banco De Occidente S.A.’s $175 Million Subordinated Notes Issuance

Reneo Pharmaceuticals’ Merger with Onkure

TMF Trust Company’s US$3,18 Million Trust Debt Securities Issuance

Oiltanking Ebytem’s US$33 Million Notes Issuance

Banco Falabella’s US$16 Million Certificates of Deposit Issuance

VAALCO Energy’s $40.2 Million Acquisition of Svenska Petroleum Exploration

Arrow Global’s Acquisition Of Amitra Capital From CPP Investment

Broadsign’s Acquisition Of OutMoove

JS Virginia Proprietary Ltd’s Financing Of Renewable Project In South Africa

Injaro Investment Advisors’ Equity Investment in NME

Dislog Group’s Acquisition of CMB Plastique Maroc

OSN’s Acquisition of a Control Stake in Anghami

McLaren’s Successful Reorganisation with Mumtalakat

Skyports Infrastructure’s Dubai Launch

Aquila Capital’s Financing Of 180MW PV Portfolio in New Zealand

KKR’s Acquisition of Healthium

Marketingforce Management’s IPO on the Hong Kong Stock Exchange

Katten Taps James Bookhout to Lead M&A Litigation in Dallas

Hinshaw Expands Health Care Practice on East Coast

BCLP Makes New Leadership Appointments

The Distinctive Character Of The ‘Vespa’ Is No Longer In Question

Cultural Heritage Sites With Restrictions On Intended Use: The Council of State Acknowledges That This Power Lies In the Hands Of The Ministry Of Culture

The Italian Revenue Agency Qualifies Directors’ Reversible Remuneration For The Purposes Of Double Taxation Agrements.

Katten Taps James Bookhout to Lead M&A Litigation in Dallas

Hinshaw Expands Health Care Practice on East Coast

Intellectual Property Partner Jeff Morton Joins Haynes Boone in Southern California

INOVIO Pharmaceuticals’ $36 Million Common Stock Offering

Author: Laura Testa